| Literature DB >> 33390002 |
Nichole K Stewart1, Marta Toth1, Anastasiya Stasyuk2, Mijoon Lee1, Clyde A Smith2,3, Sergei B Vakulenko1.
Abstract
Avibactam is a potent diazobicyclooctane inhibitor of class A and C β-lactamases. The inhibitor also exhibits variable activity against some class D enzymes from Gram-negative bacteria; however, its interaction with recently discovered class D β-lactamases from Gram-positive bacteria has not been studied. Here, we describe microbiological, kinetic, and mass spectrometry studies of the interaction of avibactam with CDD-1, a class D β-lactamase from the clinically important pathogen Clostridioides difficile, and show that avibactam is a potent irreversible mechanism-based inhibitor of the enzyme. X-ray crystallographic studies at three time-points demonstrate the rapid formation of a stable CDD-1-avibactam acyl-enzyme complex and highlight differences in the anchoring of the inhibitor by class D enzymes from Gram-positive and Gram-negative bacteria.Entities:
Keywords: Clostridioides difficile; avibactam; crystal structure; inhibition; kinetics; β-lactamase
Mesh:
Substances:
Year: 2021 PMID: 33390002 PMCID: PMC8826747 DOI: 10.1021/acsinfecdis.0c00714
Source DB: PubMed Journal: ACS Infect Dis ISSN: 2373-8227 Impact factor: 5.084